Skip to content

Innoviva, Inc. INVA Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK
AbbVie logo
AbbVieABBV
Savara logo
SavaraSVRA
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s deferred tax assets and other non-current assets?
Innoviva, Inc. (INVA) reported deferred tax assets and other non-current assets of $40.53M in Q1 2026.
How has Innoviva, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Innoviva, Inc.'s deferred tax assets and other non-current assets decreased by 1.8% year-over-year, from $41.27M to $40.53M.
What is the long-term trend for Innoviva, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Innoviva, Inc.'s deferred tax assets and other non-current assets has grown at a 185.7% compound annual growth rate (CAGR), from $214K to $40.74M.